Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Otolith Labs has developed a patented noninvasive wearable device using vestibular stimulation to treat chronic vertigo. The device uses calibrated mechanical vibrations delivered behind the ear to modulate signals in the vestibular system. Pilot studies have shown immediate symptom relief with no serious adverse events reported in over 600 subjects. The company received FDA Breakthrough Device Designation and recently completed a $20M Series A round to support pivotal trials and anticipated commercial launch pending regulatory approval. Exploratory research also suggests benefit for VR-induced cybersickness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Otolith Labs.